BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi H, Carion TW, Jiang Y, Chahine A, Steinle JJ, Berger EA. A regulatory role for β-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina. PLoS One 2017;12:e0185383. [PMID: 29095817 DOI: 10.1371/journal.pone.0185383] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Miao Z, Tang X, Schultzberg M, Zhao Y, Wang X. Plasma Resolvin D2 to Leukotriene B4 Ratio Is Reduced in Diabetic Patients with Ischemic Stroke and Related to Prognosis. Biomed Res Int 2021;2021:6657646. [PMID: 33728336 DOI: 10.1155/2021/6657646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Maisto R, Trotta MC, Petrillo F, Izzo S, Cuomo G, Alfano R, Hermenean A, Barcia JM, Galdiero M, Platania CBM, Bucolo C, D'Amico M. Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose. Front Pharmacol 2020;11:235. [PMID: 32210819 DOI: 10.3389/fphar.2020.00235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
3 Çolakoğlu M, Tunçer S, Banerjee S. Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1. Cell Prolif 2018;51:e12472. [PMID: 30062726 DOI: 10.1111/cpr.12472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
4 Ikeda T, Nakamura K, Kida T, Oku H. Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2021. [PMID: 34379187 DOI: 10.1007/s00417-021-05342-6] [Reference Citation Analysis]
5 Petrillo F, Trotta MC, Bucolo C, Hermenean A, Petrillo A, Maisto R, Pieretti G, Pietropaolo M, Ferraraccio F, Gagliano C, Galdiero M, D'Amico M. Resolvin D1 attenuates the inflammatory process in mouse model of LPS-induced keratitis. J Cell Mol Med 2020;24:12298-307. [PMID: 33058526 DOI: 10.1111/jcmm.15633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li Z, Liu Z, Lu H, Dai W, Chen J, He L. RvD1 Attenuated Susceptibility to Ischemic AKI in Diabetes by Downregulating Nuclear Factor-κ B Signal and Inhibiting Apoptosis. Front Physiol 2021;12:651645. [PMID: 34326777 DOI: 10.3389/fphys.2021.651645] [Reference Citation Analysis]
7 Trotta MC, Pieretti G, Petrillo F, Alessio N, Hermenean A, Maisto R, D'Amico M. Resolvin D1 reduces mitochondrial damage to photoreceptors of primary retinal cells exposed to high glucose. J Cell Physiol 2020;235:4256-67. [PMID: 31612492 DOI: 10.1002/jcp.29303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Busik JV. Lipid metabolism dysregulation in diabetic retinopathy. J Lipid Res 2021;62:100017. [PMID: 33581416 DOI: 10.1194/jlr.TR120000981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Botten N, Hodges RR, Li D, Bair JA, Shatos MA, Utheim TP, Serhan CN, Dartt DA. Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells. FASEB J 2019;33:8468-78. [PMID: 31013438 DOI: 10.1096/fj.201802467R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
10 Cammalleri M, Dal Monte M, Amato R, Lapi D, Bagnoli P. Novel Insights into Beta 2 Adrenergic Receptor Function in the rd10 Model of Retinitis Pigmentosa. Cells 2020;9:E2060. [PMID: 32917020 DOI: 10.3390/cells9092060] [Reference Citation Analysis]